Synergistic antimicrobial efficacy of mesoporous ZnO loaded with 4-(α-L-rhamnosyloxy)-benzyl isothiocyanate isolated from the Moringa oleifera seed

The Journal of General and Applied Microbiology
Se Rim JeonJae Sung Hwang

Abstract

The antimicrobial activities of isolated compounds from seed extracts of Moringa oleifera and synergistic antimicrobial efficacy through hybridized complex of organic-inorganic composite materials were studied. The two main components of the Moringa oleifera seed were isolated and determined to be niazimicin and 4-(α-L-rhamnosyloxy)-benzyl isothiocyanate (RBI). The antimicrobial activity of the separated compounds of the Moringa oleifera seed were tested in vitro against 3 bacterial species and 2 fungal species by the paper disc diffusion assay and broth dilution methods. Both compounds showed antimicrobial activity against tested species and RBI was more effective than niazimicin. The MIC of RBI on S. aureus, E. coli, P. aeruginosa, C. albicans, and A. niger was 0.005%, 0.1%, 0.5%, 0.5%, and 0.5%, respectively, while the MIC of niazimicin on S. aureus was 0.1%. Next, we investigated the combined antimicrobial action of mesoporous ZnO and RBI by incorporating the compound within the pore of mesoporous ZnO. The MIC of mesoporous ZnO with RBI on S. aureus, E. coli, P. aeruginosa, C. albicans, and A. niger was 0.001%, 0.01%, 0.5%, 0.1%, and 0.1%, respectively. A synergistic effect of RBI with mesoporous ZnO was shown. From these r...Continue Reading

References

Nov 28, 2001·Contact Dermatitis·E ReinhardS Scherer
Jun 10, 2004·Dermatologic Therapy·Denis Sasseville
Aug 16, 2005·Critical Reviews in Toxicology·Robert GoldenGuenter Vollmer
Jan 13, 2006·Bioresource Technology·Ping-Hsien ChuangHueih-Min Chen
Dec 18, 2007·FEMS Microbiology Letters·Nicole JonesAdhar C Manna
Feb 6, 2008·Acta Biomaterialia·Jayesh P RupareliaSuparna Mukherji
Mar 24, 2009·International Journal of Cosmetic Science·A VarvaresouC Demetzos
Jul 8, 2009·Nature Nanotechnology·Lihong LiuYi-Yan Yang
Aug 6, 2010·Bioorganic & Medicinal Chemistry·Sarot CheenprachaLeng Chee Chang
Oct 1, 2005·Nanotechnology·Jose Ruben MoronesMiguel Jose Yacaman
Dec 1, 1945·Journal of Bacteriology·Y H LOO, P S SKELL
Mar 10, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·S SreelathaP R Padma
Mar 16, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Krishna R RaghupathiAdhar C Manna
Jan 13, 2012·International Journal of Food Microbiology·Mahmoud Z SitohyAli O Osman
Jan 28, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Guo-Xiu TongXian Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.